GB946309A - Therapeutic gastric anti-secretory composition - Google Patents
Therapeutic gastric anti-secretory compositionInfo
- Publication number
- GB946309A GB946309A GB2724360A GB2724360A GB946309A GB 946309 A GB946309 A GB 946309A GB 2724360 A GB2724360 A GB 2724360A GB 2724360 A GB2724360 A GB 2724360A GB 946309 A GB946309 A GB 946309A
- Authority
- GB
- United Kingdom
- Prior art keywords
- diallylmelamine
- methyl
- gastric
- secretory
- salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
946,309. Gastric anti-secretory medicines. UPJOHN CO. Aug. 5, 1960 [Sept. 2, 1959], No. 27243/60. Heading A5B. An oral pharmaceutical preparation effective in the inhibition of gastric secretion and having a low anti-cholinergic effect comprises diallylmelamine or a non-toxic salt thereof and a pharmaceutical carrier. Suitable salts are the sulphate, tartrate, dihydrochloride, acetate, citrate and phosphate. Optional additions are (a) antacids such as calcium carbonate, magnesium oxide, aluminium hydroxide and magnesium trisilicate; (b) sedatives such as phenobarbital and 3,3 - diethyl - 5 - methyl - 2,4- piperidinedione; (c) psychotherapeutic agents such as (2-ethyl crotonyl) urea, reserpine and meprobamate; (d) antihistamines such as chlorpheniramine maleate, pyrilamine maleate; and (e) muscle relaxants such as 5-chlorobenzoxazolidine and 2 - (p - chlorophenyl) - 3- methyl - 2,3 - butanediol. The diallylmelamine, or a salt thereof, is used in dosage unit form containing 0.5 to 350 mgs. active ingredient. Suitable forms are capsules, pills, pilules, tablets, elixirs, solutions, suspensions and syrups.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US83758759A | 1959-09-02 | 1959-09-02 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB946309A true GB946309A (en) | 1964-01-08 |
Family
ID=25274892
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB2724360A Expired GB946309A (en) | 1959-09-02 | 1960-08-05 | Therapeutic gastric anti-secretory composition |
Country Status (2)
Country | Link |
---|---|
BE (1) | BE594644A (en) |
GB (1) | GB946309A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2019646A1 (en) * | 1968-10-02 | 1970-07-03 | Science Union & Cie |
-
1960
- 1960-08-05 GB GB2724360A patent/GB946309A/en not_active Expired
- 1960-09-01 BE BE594644A patent/BE594644A/en unknown
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2019646A1 (en) * | 1968-10-02 | 1970-07-03 | Science Union & Cie |
Also Published As
Publication number | Publication date |
---|---|
BE594644A (en) | 1961-03-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Spiro et al. | The effect of adrenocorticotrophic hormone upon uropepsin excretion | |
ES2008759A6 (en) | Crystalline hydrate of oral cephalosporin and its composition | |
GB1517480A (en) | Opiate analgesic formulation with a low potential for abuse | |
GB1274271A (en) | Improvements in or relating to propionic acid derivatives | |
GB1247976A (en) | Pharmaceutical compositions, amino acid ester compounds, and methods for their production | |
US3829561A (en) | Iron preparation and process for its manufacture | |
US2789938A (en) | Method of producing a diuretic effect with p-carboxybenzenesulfonamide | |
GB946309A (en) | Therapeutic gastric anti-secretory composition | |
DE3571984D1 (en) | New substituted benzimidazoles, a process for their preparation and their use for inhibiting gastric acid secretion | |
GB1487334A (en) | Pharmaceutical preparations comprising lisuride and/or physiologically tolerable salts thereof | |
GB1296510A (en) | ||
US4221783A (en) | Composition and method for the treatment of duodenal ulcers, gastritis and gastro-duodenitis | |
GB983588A (en) | Improvements relating to pharmaceutical compositions containing pantothenic acid | |
US2768115A (en) | Penicillin-aspirin tablets | |
USRE28636E (en) | Antibacterial composition containing 5-methyl-3-sulfanilamidoisoxazole and trimethoxybenyl pyrimidine | |
US3676549A (en) | Administration of alkali metal salts of salicylamide | |
ES8601687A1 (en) | pH independent controlled releasable tablets. | |
GB1394757A (en) | Lysino-calcium chloride | |
US2854376A (en) | Antacid composition | |
GB1357813A (en) | Effervescent composition for the treatment of heart diseases | |
IE35419L (en) | Pharmaceutical composition containing cyclobenzaprine | |
DE3380294D1 (en) | Pharmaceutical compositions in oral dosage form | |
GB911482A (en) | Pharmaceutical tablets comprising a synergistic combination including salts of ª--phenoxyethyl penicillin | |
GB1098417A (en) | Pharmaceutical compositions having hypotensive activity | |
GB1354640A (en) | Derivatives of cysteine |